Updates from FDA's Division of Drug Marketing, Advertising, and Communications about its Healthcare Provider Outreach
FDA’s Issues first Warning Letter from Bad Ad Complaint
On December 3rd, FDA’s Division of Drug Marketing, Advertising, and Communications (DDMAC) issued a Warning Letter to Hill Dermaceuticals for misleading promotion of Derma-Smoothe/FS Topical Oil. This is the first enforcement action taken as a result of information sent to FDA via the Bad Ad Program. It shows that collaboration between
FDA and the Nation’s healthcare professionals can curtail misleading prescription drug promotion.
To read the letter:
http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm236073.htm
FDA’s message of recognizing and reporting misleading prescription drug promotion is reaching healthcare professionals and they are responding. FDA is optimistic that as our message reaches more HCPs, we will be able to stop more misleading promotion. We also hope that industry recognizes that healthcare professionals, by collaborating with FDA
through Bad Ad, are sending a strong message that misleading promotion, wherever it occurs, will not be tolerated.
The Bad Ad Program
The Bad Ad Program is FDA’s educational outreach program designed to educate healthcare professionals about the role that they can play in helping the agency make sure that prescription drug advertising and promotion is truthful and not misleading. The Bad Ad Program is administrated by the agency’s Division of Drug Marketing, Advertising, and Communications (DDMAC) in the Center for
Drug Evaluation and Research. It helps healthcare professionals recognize misleading prescription drug promotion and provide them with an easy way to report this activity to the agency.
This is an automated message delivery system. Replying to this message will not reach DDMAC staff.
- If you would like to speak with a DDMAC representative, please contact us at: 877-RX-DDMAC (877-793-3622).
- You can also e-mail us at BadAd@xxxxxxxxxxx.
- For additional information, please visit the BadAd Web page.
Manage your FDA Subscriptions:
- Update your preferences or unsubscribe
- Questions about this service? support@xxxxxxxxxxxxxxx
- Other inquiries? webmail@xxxxxxxxxx
U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420
